Immunotherapy

For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit Singh, Kelly M Hotchkiss, Aditya A Mohan, Jessica L Reedy, John H Sampson, Mustafa Khasraw

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003679; DOI: 10.1136/jitc-2021-003679
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
Luis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, Richa Sharma, Lenore Monterroza, Rohini N. Guin, Sarah G. Samaranayake, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Mala Shanmugam, Periasamy Selvaraj

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002614; DOI: 10.1136/jitc-2021-002614
Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
Andrew D Kelly, Karthikeyan Murugesan, Zheng Kuang, Meagan Montesion, Jeffrey S Ross, Lee A Albacker, Richard S P Huang, Douglas I Lin, Umut Demirci, James Creeden

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003550; DOI: 10.1136/jitc-2021-003550
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
Saisha A Nalawade, Paul Shafer, Pradip Bajgain, Mary K McKenna, Arushana Ali, Lauren Kelly, Jarrett Joubert, Stephen Gottschalk, Norihiro Watanabe, Ann Leen, Robin Parihar, Juan Fernando Vera Valdes, Valentina Hoyos

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003237; DOI: 10.1136/jitc-2021-003237
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
Sara Lonardi, Alessandra Anna Prete, Federica Morano, Marco Messina, Vincenzo Formica, Domenico Cristiano Corsi, Corrado Orciuolo, Giovanni Luca Frassineti, Maria Giulia Zampino, Mariaelena Casagrande, Gianluca Masi, Monica Ronzoni, Mario Scartozzi, Angela Buonadonna, Stefania Mosconi, Margherita Ratti, Andrea Sartore-Bianchi, Emiliano Tamburini, Michele Prisciandaro, Francesca Bergamo, Massimiliano Spada, Salvatore Corallo, Valentina Vettore, Fotios Loupakis, Matteo Fassan, Paola Del Bianco, Vittorina Zagonel, Filippo Pietrantonio

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002996; DOI: 10.1136/jitc-2021-002996
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Eline van Diest, Patricia Hernández López, Angelo D Meringa, Anna Vyborova, Froso Karaiskaki, Sabine Heijhuurs, Jan Gumathi Bormin, Sanne van Dooremalen, Mara J T Nicolasen, Lucrezia C D E Gatti, Inez Johanna, Trudy Straetemans, Zsolt Sebestyén, Dennis X Beringer, Jürgen Kuball

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003850; DOI: 10.1136/jitc-2021-003850
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Fangwen Zou, David Faleck, Anusha Thomas, Jessica Harris, Deepika Satish, Xuemei Wang, Aline Charabaty, Marc S Ernstoff, Isabella C Glitza Oliva, Stephen Hanauer, Jennifer McQuade, Michel Obeid, Amishi Shah, David M Richards, Elad Sharon, Jedd Wolchok, John Thompson, Yinghong Wang

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003277; DOI: 10.1136/jitc-2021-003277
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
David Hsiehchen, Magdalena Espinoza, Cristina Valero, Chul Ahn, Luc G T Morris

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003683; DOI: 10.1136/jitc-2021-003683
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment
Shusuke Kawashima, Takashi Inozume, Masahito Kawazu, Toshihide Ueno, Joji Nagasaki, Etsuko Tanji, Akiko Honobe, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yasuhiro Nakamura, Tomonori Kawasaki, Yukiko Kiniwa, Osamu Yamasaki, Satoshi Fukushima, Yuzuru Ikehara, Hiroyuki Mano, Yutaka Suzuki, Hiroyoshi Nishikawa, Hiroyuki Matsue, Yosuke Togashi

Journal for ImmunoTherapy of Cancer May 2022, 9 (11) e003134; DOI: 10.1136/jitc-2021-003134
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
Xiaofeng Chen, Deqiang Wang, Jing Liu, Jingrong Qiu, Jun Zhou, Jieer Ying, Yan Shi, Zhaoxia Wang, Haizhou Lou, Jiuwei Cui, Jingdong Zhang, Yunpeng Liu, Fengjiao Zhao, Lanlan Pan, Jianyi Zhao, Dongqin Zhu, Shiqing Chen, Xiangcheng Li, Xue Li, Liuqing Zhu, Yang Shao, Yongqian Shu

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003214; DOI: 10.1136/jitc-2021-003214

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages